Pith. sign in

REVIEW 3 major objections 6 minor 176 references

Quantum Dots as Functional Nanosystems for Enhanced Biomedical Applications

T0 review · 3 major / 6 minor · reviewed 2026-08-07 · deepseek-v4-flash

Challenge this review Re-run · record.json Download PDF Read on arXiv ↗ Review JSON

Pith's one-line read This review argues that quantum dots hold promise as imaging agents, biosensors, and drug carriers, but only if their toxicity is carefully managed.

desk verdict A serviceable QD review, but the 'no system can image while delivering' claim contradicts its own theranostics examples—fix that before trusting it. read the letter →

arxiv 2505.15705 v1 pith:RF45KJAX submitted 2025-05-21 physics.bio-ph physics.med-phq-bio.BM

Pronama Biswas , Asmita Saha , Bhoomika Sridhar , Anwesha Patel , Belaguppa Manjunath Ashwin Desai This is my paper · ORCID
classification physics.bio-phphysics.med-phq-bio.BM
keywords quantumdotsbioimagingdrugdeliverybiosensorstoxicitynanomedicinesurfacemodificationmultimodalimaging
verification ladder T0 review T1 audit T2 compute T3 formal

The pith

A machine-rendered reading of the paper's core claim, the machinery that carries it, and where it could break.

The reading

Quantum dots are nanoscale semiconductor crystals whose size controls the color of light they emit, and this review gathers evidence that they can double as imaging probes, sensors, and drug-delivery vehicles. The paper's central claim is that this versatility makes them valuable for bioimaging, drug delivery, biosensing, photodynamic therapy, and tissue engineering, once their well-documented toxicity is brought under control. It argues that surface modifications, protective coatings, and biodegradable materials can reduce the accumulation and organ damage that currently block clinical use. If that is right, quantum dots could move from lab tools to practical diagnostics and therapies, and the remaining bottleneck is safety regulation rather than basic capability.

What carries the argument

The load-bearing object is the quantum dot itself: a semiconductor nanocrystal 1–10 nm in diameter whose quantum confinement makes its emission wavelength shift with size, while its large surface-to-volume ratio provides docking sites for drugs, antibodies, and polymers. This dual nature—optical behavior set by quantum physics, chemical behavior set by surface chemistry—is what lets one platform serve as fluorophore, biosensor, and drug carrier. The paper's secondary mechanism is surface modification: ligand exchange, silanization, and polymer encapsulation are the techniques it says can convert toxic, water-insoluble dots into biocompatible probes without destroying the optical properties that make them useful.

What would settle it

A decisive check is to search the cited literature for any formulation that simultaneously maintains fluorescence in vivo, delivers a drug to a target site, and clears from the body without organ accumulation; if no such case exists, the paper's claim that toxicity is a manageable hurdle rather than a fundamental constraint loses its support.

Watch

Extended reading notes

Core claim

On the paper's own terms, the central discovery is that the size-tunable fluorescence, high quantum yield, and photostability of quantum dots let a single nanomaterial act as a bright, long-lived contrast agent, a targeted drug carrier, and a sensor all at once. The review assembles a wide survey showing where each of these roles has already been demonstrated—tumor imaging in mice, doxorubicin delivery via pH-responsive dots, multimodal MRI/fluorescence probes, and FRET-based pesticide detection. It then argues that the main obstacle is not functionality but safety: cadmium-based cores can release toxic ions, and particles that are too large to clear from the body can accumulate in liver, kidney, lung, and brain. The paper concludes that with surface engineering and careful dose control these risks are manageable, and that quantum dots therefore remain a promising route to improved diagnostics and targeted therapy.

Load-bearing premise

The review's conclusions depend on the assumption that the 176 studies it cites give a true and representative picture of what quantum dots can and cannot do; a biased or incomplete citation base would shift the balance between promise and toxicity risk.

Editorial extensions

If this is right

  • If the toxicity hurdles are overcome, QD contrast agents could replace organic dyes in clinical microscopy, giving brighter, longer-lived signals from a single excitation source.
  • QD platforms that carry a drug and an imaging tag could make theranostics practical, letting clinicians see where a therapy is going while it is delivered.
  • Surface-modified carbon and graphene quantum dots, being less toxic than cadmium-based dots, could be the first QD formulations to reach clinical trials.
  • Because size, coating, and dose all affect toxicity, the paper implies that regulatory approval will need formulation-specific safety assessments rather than a single class-wide verdict.

Reading between the lines

Editorial extensions of the paper, not claims the author makes directly.

  • The paper's optimism about surface modifications carries an untested assumption that toxicity reduction will not destroy quantum yield; a direct comparison of fluorescence retention in coated versus uncoated dots would test that trade-off.
  • The assertion that no known system can simultaneously deliver a drug and image the delivery is contradicted by the same paper's theranostics examples, so that statement should be treated as a claim to verify rather than a settled fact.
  • The review's emphasis on carbon and graphene dots hints that heavy-metal-free compositions, not just coatings, may be the fastest route to clinical translation, which would shift research investment toward surface chemistry and clearance mechanisms.
  • A standardized in vivo toxicity protocol applied across all major QD classes would let the scattered dose-and-model data in this review be compared fairly; the paper itself does not provide such a protocol.
Share X Bluesky LinkedIn Reddit HN

Signed reviews

No signed human review yet.

Editorial analysis

A structured set of objections, weighed in public.

Desk editor's note, referee report, and a circularity audit.

Referee Report

3 major / 6 minor

Summary. This manuscript is a narrative review of quantum dots (QDs) in biomedical applications. It surveys QD types and classifications, synthesis approaches, surface modification strategies, characterization techniques, and applications in bioimaging, multimodal imaging, drug delivery, theranostics, biosensing, and disease diagnosis. It also reviews QD toxicity mechanisms and mitigation strategies. The paper's central thesis, stated in the Conclusion, is that QDs possess unique optical and physical properties that make them promising tools for bioimaging, drug delivery, sensing, photodynamic therapy, and tissue engineering, while toxicity and biocompatibility remain key hurdles that can be addressed by surface modification, encapsulation, and biodegradable materials.

Significance. The review is broad in scope and cites a substantial number of recent references, including an explicit discussion of toxicity-mitigation strategies such as surface ligand exchange, silanization, polymer encapsulation, and doping. It provides useful summary tables and figures that could serve as an orientation for non-specialist readers. However, it is a narrative review without new experimental data or a systematic methodology, so its value rests entirely on the accuracy and representativeness of the cited literature. The internal inconsistency in the theranostics claim and the classification errors in Table 1 currently limit the reliability of the review as a reference document.

major comments (3)
  1. [Targeted Drug Delivery Using QDs] The sentence 'no known system currently can simultaneously target drug delivery and imaging the delivery process' is directly contradicted by the paper's own 'QDs for Theranostics' section, which cites Fe3O4-ZnO core-shell MQDs that 'visualize and treat tumors simultaneously' (Ref [108]), CdTe QD theranostic nanocapsules combining drug delivery with imaging (Ref [109]), FACS-Mn-ZnS and protein-QD nanohybrids used for both drug release and bioimaging (Ref [119]), and MoS2-PEG-DOX as a 'traceable and pH-responsive chemotherapeutic drug delivery' system (Ref [124]). Because theranostic dual function is a principal advantage claimed for QDs in the Conclusion, this unsupported absolute claim must be corrected or removed.
  2. [Elemental Composition; Table 1] The classification of QDs is internally inconsistent. Group VI A is described as comprising carbon, silicon, and germanium, but those elements belong to group IV A; CuInS2 appears as the example for both I B-VI A and I B-III A-VI A; and the abbreviation PQDs is defined in the table footnote as 'peptide-paramagnetic QDs' while the row entry refers to perovskite QDs (Formamidinium PbBr3), where PQD is the standard abbreviation for perovskite quantum dots. These errors undermine the classification system that organizes the review.
  3. [Methods (implicit); Conclusion] The review provides no search strategy, inclusion criteria, or quality assessment for the 176 cited references. The risk-benefit synthesis in the Conclusion rests on an unstated and potentially unrepresentative citation selection; this is particularly problematic because, as noted above, one absolute claim is directly contradicted by the paper's own cited examples. The authors should either state the literature retrieval method or soften universal claims to match the evidence actually presented.
minor comments (6)
  1. [Throughout] The heading 'Types of QDS' and many in-text occurrences of 'QDS' should be 'QDs'.
  2. [Size of QDs] The statement that small QDs have 'better tissue penetration and reduced scattering effects' is physically incorrect: shorter-wavelength emission from small QDs scatters more strongly and penetrates less deeply than longer-wavelength emission. Please revise this sentence.
  3. [Toxicity Mechanism and Toxicity Evaluation of QDs] The text uses 'CdSe/Zn QDs' where 'CdSe/ZnS QDs' is presumably intended, and '10nmol kg-1' should be formatted as '10 nmol kg-1' for consistency.
  4. [Fig. 7 caption] The caption uses 'Foster Resonance Energy Transfer'; the correct name is Förster Resonance Energy Transfer.
  5. [Surface modifications of QDs] The phrase 'Surface ligand exchange (ap exchange)' contains a typo; it should read 'ligand exchange'.
  6. [Conclusion] The Conclusion introduces tissue engineering as an application of QDs without any prior discussion in the body of the review; either add a corresponding section or remove the claim.

Circularity Check

0 steps flagged · score 1.0 of 10

Narrative review with one non-load-bearing self-citation and no circular derivation chain.

full rationale

This manuscript is a narrative review with no derivations, fitted parameters, or uniqueness claims. Its central claims—that QDs have tunable emission, high photostability, and high quantum yield; that they are useful in bioimaging, drug delivery, and biosensing; that toxicity is a major hurdle; and that surface modification can mitigate toxicity—are supported by 176 external references and are not derived from any input within the paper. The only self-citation, Ref. [36] (Misra, Das, Biswas, Nanda), appears in Table 1 and in the 'Doped QDs' paragraph as an example of 'Mn-doped ZnSe QDs'; it is illustrative only and the review's conclusions do not rest on it. The paper's assertion that 'no known system currently can simultaneously target drug delivery and imaging the delivery process' conflicts with its own cited theranostics examples (e.g., Refs. [108], [109], [119], [124]), but this is an internal consistency or factual error, not a circular step: no equation or definition reduces to its own input, and no prediction is statistically forced by a fit. Thus the paper is self-contained as a review, with only a minor, non-load-bearing self-citation.

Assumptions & free parameters 0 free parameters · 3 assumptions · 0 invented entities

No free parameters or invented entities appear because the paper is a narrative review. The central claims rest on the reliability and representativeness of the cited literature, plus the standard physical assumption that quantum dot size tunes optical properties. Internal inconsistencies, such as the PQDs abbreviation mismatch and the 'no known system' overclaim, weaken but do not by themselves invalidate the review's general thesis.

assumptions (3)
  • domain assumption The cited primary literature accurately reports experimental observations.
    All statements about QD optical properties, toxicity, and applications are inherited from references [1]-[176]; no primary data are presented in this review.
  • domain assumption The selected references are representative of the broader field of QD biomedicine.
    The review generalizes about QD promise and challenges without a systematic search or inclusion criteria; an unrepresentative selection would change the conclusions.
  • domain assumption Quantum dots are semiconductor nanoparticles whose size tunes their electronic and optical properties.
    Invoked throughout the Introduction and the 'Size of QDs' section as the basis for classifying QDs and explaining their emission behavior.

how reviews work

0 comments
Cite this review

Pith. "Pith review of Quantum Dots as Functional Nanosystems for Enhanced Biomedical Applications." pith.science (2026). https://pith.science/paper/RF45KJAX

@misc{pith2026250515705,
  author       = {Pith},
  title        = {Pith review of: Quantum Dots as Functional Nanosystems for Enhanced Biomedical Applications},
  year         = {2026},
  howpublished = {\url{https://pith.science/paper/RF45KJAX}},
  note         = {Machine review of arXiv:2505.15705}
}
read the original abstract

Quantum dots (QDs) have emerged as promising nanomaterials with unique optical and physical properties, making them highly attractive for various applications in biomedicine. This review provides a comprehensive overview of the types, modes of synthesis, characterization, applications, and recent advances of QDs in the field of biomedicine, with a primary focus on bioimaging, drug delivery, and biosensors. The unique properties of QDs, such as tunable emission spectra, long-term photostability, high quantum yield, and targeted drug delivery, hold tremendous promise for advancing diagnostics, therapeutics, and imaging techniques in biomedical research. However, several significant hurdles remain before their full potential in the biomedical field, like bioaccumulation, toxicity, and short-term stability. Addressing these hurdles is essential to effectively incorporate QDs into clinical use and enhance their influence on healthcare outcomes. Furthermore, the review conducts a critical analysis of potential QD toxicity and explores recent progress in strategies and methods to mitigate these adverse effects, such as surface modification, surface coatings, and encapsulation. By thoroughly examining current research and recent advancements, this comprehensive review offers invaluable insights into both the future possibilities and the challenges that lie ahead in fully harnessing the potential of QDs in the field of biomedicine, promising a revolution in the landscape of medical diagnostics, therapies, and imaging technologies.

Figures

Figures reproduced from arXiv: 2505.15705 by the authors.

Figure 1
Figure 1. Classification of Quantum Dots (QDs) based on structure. Core-Shell QD: covering the core with a semiconductor material with a larger band gap, like ZnS, can increase stability and quantum yield while simultaneously neutralizing the toxicity of the core by preventing photo-oxidative conditions like Ultraviolet (UV) and air from exposing reactive Cd+2 and Te+2 ions. Alloyed QD: Indium is spread across InGaAs QDs; the… view at source ↗
Figure 2
Figure 2. Methods of surface modification of Quantum Dots (QDs). (a) The diagram depicts the surface ligand exchange where a hydrophobic molecule TOPO on QD is being replaced by a hydrophilic molecule 2- Aminoethanethiol, which helps improve the solubility of QD. Adapted from [74] Copyright 2018, Wiley. (b) Silanization is the process by which adenosine 5’-monophosphate (AMP) conjugated Quantum Dots (QDs) are transformed into… view at source ↗

Discussion (0). Continue with ORCID to comment.

Reference graph

Works this paper leans on

176 extracted references · 79 canonical work pages

  1. [36]

    EGFR targeted Mn-doped ZnO fluorescent nanocrystals for cancer theranostic application

    Misra R, Das M, Biswas P, Nanda A. EGFR targeted Mn-doped ZnO fluorescent nanocrystals for cancer theranostic application. Materials Today Communications. 2021; 26: 102170

    2021

  2. [108]

    Multifunctional magnetic quantum dots for cancer theranostics

    Singh SP. Multifunctional magnetic quantum dots for cancer theranostics. Journal of Biomedical Nanotechnology. 2011; 7: 95– 97

    work page 2011

  3. [109]

    Layer -by-layer gelatin/chondroitin quantum dots -based nanotheranostics: combined rapamycin/celecoxib delivery and cancer imaging

    AbdElhamid AS, Helmy MW, Ebrahim SM, Bahey -El-Din M, Zayed DG, Zein El Dein EA, et al . Layer -by-layer gelatin/chondroitin quantum dots -based nanotheranostics: combined rapamycin/celecoxib delivery and cancer imaging. Nanomedicine (London, England). 2018; 13: 1707–1730

    work page 2018

  4. [119]

    Hybrid quantum dot-based theranostic nanomedicines for tumor-targeted drug delivery and cancer imaging

    Zayed DG, AbdElhamid AS, Freag MS, Elzoghby AO. Hybrid quantum dot-based theranostic nanomedicines for tumor-targeted drug delivery and cancer imaging. Nanomedicine (London, England). 2019; 14: 225–228

    work page 2019

  5. [124]

    PEGylated MoS 2 quantum dots for traceable and pH -responsive chemotherapeutic drug delivery

    Liu L, Jiang H, Dong J, Zhang W, Dang G, Yang M, et al. PEGylated MoS 2 quantum dots for traceable and pH -responsive chemotherapeutic drug delivery. Colloids and Surfaces. B, Biointerfaces. 2020; 185: 110590

    work page 2020

  6. [1]

    Quantum dots in imaging, drug delivery and sensor applications

    Matea CT, Mocan T, Tabaran F, Pop T, Mosteanu O, Puia C, et al. Quantum dots in imaging, drug delivery and sensor applications. International Journal of Nanomedicine. 2017; 12: 5421–5431

    2017

  7. [2]

    Role of quantum dots in pharmaceutical and biomedical analysis, and its application in drug delivery

    Badıllı U, Mollarasouli F, Bakirhan N K, Ozkan Y, Ozkan SA. Role of quantum dots in pharmaceutical and biomedical analysis, and its application in drug delivery. TrAC Trends in Analytical Chemistry. 2020; 131: 116013

    2020

  8. [3]

    Application of semiconductor quantum dots in bioimaging and biosensing

    Martynenko IV, Litvin AP, Purcell-Milton F, Baranov AV, Fedorov AV, Gun'ko YK. Application of semiconductor quantum dots in bioimaging and biosensing. Journal of Materials Chemistry. B. 2017; 5: 6701–6727

    2017

Show all 176 references
  1. [4]

    Using of Quantum Dots in Biology and Medicine

    Pleskova S, Mikheeva E, Gornostaeva E. Using of Quantum Dots in Biology and Medicine. Advances in Experimental Medicine and Biology. 2018; 1048: 323–334

    2018

  2. [5]

    Coming attractions for semiconductor quantum dots

    Smyder JA, Krauss TD. Coming attractions for semiconductor quantum dots. Materials Today. 2011; 14: 382–387

    2011

  3. [6]

    Quantum dots: Prospectives, toxicity, advances and applications

    Gidwani B, Sahu V, Shukla SS, Pandey R, Joshi V, Jain VK, et al. Quantum dots: Prospectives, toxicity, advances and applications. Journal of Drug Delivery Science and Technology. 2021; 61: 102308

    2021

  4. [7]

    Doped quantum dots for chemo/biosensing and bioimaging

    Wu P, Yan XP. Doped quantum dots for chemo/biosensing and bioimaging. Chemical Society Reviews. 2013; 42: 5489–5521

    2013

  5. [8]

    Semiconducting quantum dots: Modification and applications in biomedical science

    Wang L, Xu D, Gao J, Chen X, Duo Y , Zhang H. Semiconducting quantum dots: Modification and applications in biomedical science. Science China Materials. 2020; 63: 1631–1650

    2020

  6. [9]

    Evaluating pharmacokinetics and toxicity of luminescent quantum dots

    Wu X, Tian F, Zhao JX, Wu M. Evaluating pharmacokinetics and toxicity of luminescent quantum dots. Expert Opinion on Drug Metabolism & Toxicology. 2013; 9: 1265–1277

    2013

  7. [10]

    Quantum Dots: A Review from Concept to Clinic

    Kargozar S, Hoseini SJ, Milan PB, Hooshmand S, Kim HW, Mozafari M. Quantum Dots: A Review from Concept to Clinic. Biotechnology Journal. 2020; 15: e2000117

    2020

  8. [11]

    Polymer coating of quantum dots --a powerful tool toward diagnostics and sensorics

    Hezinger AFE, Tessmar J, Göpferich A. Polymer coating of quantum dots --a powerful tool toward diagnostics and sensorics. European Journal of Pharmaceutics and Biopharmaceutics: Official Journal of Arbeitsgemeinschaft Fur Pharmazeutische Verfahrenstechnik E.V. 2008; 68: 138–152

    2008

  9. [12]

    Effective theory of monolayer TMDC double quantum dots

    David A, Burkard G, Kormányos A. Effective theory of monolayer TMDC double quantum dots. 2D Mater. 2018; 5: 035031

    2018

  10. [13]

    Light-emitting MXene quantum dots

    Sharbirin AS, Akhtar S, Kim J. Light-emitting MXene quantum dots. Opto-Electronic Advances. 2021; 4: 200077–200077

    2021

  11. [14]

    Perovskite Quantum Dots and Their Application in Light-Emitting Diodes

    Wang HC, Bao Z, Tsai HY, Tang AC, Liu RS. Perovskite Quantum Dots and Their Application in Light-Emitting Diodes. Small (Weinheim an Der Bergstrasse, Germany). 2018; 14: 10.1002/smll.201702433

    2018 doi

  12. [15]

    Quantum Dots Nanoparticles for Biomedical Applications (pp 243–65)

    Maxwell T, Nogueira Campos M G, Smith S, Doomra M, Thwin Z , Santra S . Quantum Dots Nanoparticles for Biomedical Applications (pp 243–65). Elsevier: Location. 2020

    2020

  13. [16]

    Quantum Dot Optoelectronic Devices

    Yu P, Wang ZM. Quantum Dot Optoelectronic Devices. Springer International Publishing: Cham. 2020

    2020

  14. [17]

    Carbon quantum dots with high quantum yield prepared by heterogeneous nucleation processes

    Chang C-Y, Venkatesan S, Herman A, Wang C-L, Teng H, Lee Y-L. Carbon quantum dots with high quantum yield prepared by heterogeneous nucleation processes. Journal of Alloys and Compounds. 2023 938 168654

    2023

  15. [18]

    Long -term persistence and spectral blue shifting of quantum dots in vivo

    Fitzpatrick JAJ, Andreko SK, Ernst LA, Waggoner AS, Ballou B, Bruchez MP. Long -term persistence and spectral blue shifting of quantum dots in vivo. Nano Letters. 2009; 9: 2736–2741

    2009

  16. [19]

    Pharmaceutical potential of quantum dots

    Jha S, Mathur P, Ramteke S, Jain NK. Pharmaceutical potential of quantum dots. Artificial Cells, Nanomedicine, and Biotechnology. 2018; 46: 57–65

    2018

  17. [20]

    Simple and accurate quantification of quantum yield at the single-molecule/particle level

    Hu J, Zhang CY. Simple and accurate quantification of quantum yield at the single-molecule/particle level. Analytical Chemistry. 2013; 85: 2000–2004

    2013

  18. [21]

    High quantum yield ZnO quantum dots synthesizing via an ultrasonication microreactor method

    Yang W, Yang H, Ding W, Zhang B, Zhang L, Wang L, et al. High quantum yield ZnO quantum dots synthesizing via an ultrasonication microreactor method. Ultrasonics Sonochemistry. 2016; 33: 106–117

    2016

  19. [22]

    Electrochemical synthesis of small -sized red fluorescent graphene quantum dots as a bioimaging platform

    Tan X, Li Y, Li X, Zhou S, Fan L, Yang S. Electrochemical synthesis of small -sized red fluorescent graphene quantum dots as a bioimaging platform. Chemical Communications (Cambridge, England). 2015; 51: 2544–2546

    2015

  20. [23]

    Over 40 cd/A efficient green quantum dot electroluminescent device comprising uniquely large-sized quantum dots

    Lee KH, Lee JH, Kang HD, Park B, Kwon Y, Ko H, et al. Over 40 cd/A efficient green quantum dot electroluminescent device comprising uniquely large-sized quantum dots. ACS Nano. 2014; 8: 4893–4901

    2014

  21. [24]

    Are quantum dots ready for in vivo imaging in human subjects? Nanoscale Research Letters

    Cai W, Hsu AR, Li ZB, Chen X. Are quantum dots ready for in vivo imaging in human subjects? Nanoscale Research Letters. 2007; 2: 265–281

    2007

  22. [25]

    Graphene quantum dots: multifunctional nanoplatforms for anticancer therapy

    Iannazzo D, Ziccarelli I, Pistone A . Graphene quantum dots: multifunctional nanoplatforms for anticancer therapy. Journal of Materials Chemistry B. 2017; 5: 6471–6489

    2017

  23. [26]

    Fabrication of a light -emitting device based on the CdS/ZnS spherical quantum dots

    Hasanirokh K, Asgari A , Mohammadi S. Fabrication of a light -emitting device based on the CdS/ZnS spherical quantum dots . Journal of the European Optical Society-Rapid Publications. 2021; 17: 26

    2021

  24. [27]

    Light-emitting diodes of colloidal quantum dots and nanorod heterostructures for future emissive displays

    Jiang Y, Cho S -Y, Shim M. Light-emitting diodes of colloidal quantum dots and nanorod heterostructures for future emissive displays. Journal of Materials Chemistry C. 2018; 6: 2618–2634

    2018

  25. [28]

    Au@polymer core-shell nanoparticles for simultaneously enhancing efficiency and ambient stability of organic optoelectronic devices

    Kim T, Kang H, Jeong S, Kang DJ, Lee C, Lee CH, et al. Au@polymer core-shell nanoparticles for simultaneously enhancing efficiency and ambient stability of organic optoelectronic devices. ACS Applied Materials & Interfaces. 2014; 6: 16956–16965

    2014

  26. [29]

    Applicability of Quantum Dots in Biomedical Science Ionizing Radiation Effects and Applications

    Brkić S. Applicability of Quantum Dots in Biomedical Science Ionizing Radiation Effects and Applications . In Djezzar B (ed.) InTech: Rijeka. 2018

    2018

  27. [30]

    Semiconductor quantum dots as fluorescent probes for in vitro and in vivo bio- molecular and cellular imaging

    Rizvi SB, Ghaderi S, Keshtgar M, Seifalian AM. Semiconductor quantum dots as fluorescent probes for in vitro and in vivo bio- molecular and cellular imaging. Nano Reviews. 2010; 1: 10.3402/nano.v1i0.5161

    2010 doi

  28. [31]

    Core -shell particles for drug -delivery, bioimaging, sensing, and tissue engineering

    Jenjob R, Phakkeeree T, Crespy D . Core -shell particles for drug -delivery, bioimaging, sensing, and tissue engineering. Biomaterials Science. 2020; 8: 2756–2770

    2020

  29. [32]

    The role of surface ligands in determining the electronic properties of quantum dot solids and their impact on photovoltaic figure of merits

    Goswami PN, Mandal D, Rath AK. The role of surface ligands in determining the electronic properties of quantum dot solids and their impact on photovoltaic figure of merits. Nanoscale. 2018; 10: 1072–1080

    2018

  30. [33]

    The effect of shape and size in the stability of triangular Janus MoSSe quantum dots

    Paez-Ornelas JI, Ponce-Pérez R, Fernández-Escamilla HN, Hoat DM, Murillo-Bracamontes EA, Moreno-Armenta MG, et al. The effect of shape and size in the stability of triangular Janus MoSSe quantum dots. Scientific Reports. 2021; 11: 21061

    2021

  31. [34]

    A review on alloyed quantum dots and their applications as photocatalysts

    Sahu J, Prusty D, Mansingh S, Parida K. A review on alloyed quantum dots and their applications as photocatalysts. International Journal of Hydrogen Energy. 2023; 48: 29097–29118

    2023

  32. [35]

    Functionalized near-infrared quantum dots for in vivo tumor vasculature imaging

    Hu R, Yong KT, Roy I, Ding H, Law WC, Cai H, et al. Functionalized near-infrared quantum dots for in vivo tumor vasculature imaging. Nanotechnology. 2010; 21: 145105

    2010

  33. [37]

    N doped-carbon quantum dots with ultra-high quantum yield photoluminescent property conjugated with folic acid for targeted drug delivery and bioimaging applications

    Khoshnood A, Farhadian N, Abnous K, Matin M M, Ziaee N, Yaghoobi E. N doped-carbon quantum dots with ultra-high quantum yield photoluminescent property conjugated with folic acid for targeted drug delivery and bioimaging applications . Journal of Photochemistry and Photobiolog...

    2023

  34. [38]

    Pure and Fe3+ -doped ZnS quantum dots as novel and efficient nanophotocatalysts: Synthesis, characterization and use for decolorization of Victoria blue R

    Shamsipur M, Reza Rajabi H , Khani O. Pure and Fe3+ -doped ZnS quantum dots as novel and efficient nanophotocatalysts: Synthesis, characterization and use for decolorization of Victoria blue R . Materials Science in Semiconductor Processing. 2013; 16: 1154–1161

    2013

  35. [39]

    Photophysical properties of ZnS quantum dots Journal of Physics and Chemistry of Solids

    Li Y, Ding Y, Zhang Y, Qian Y. Photophysical properties of ZnS quantum dots Journal of Physics and Chemistry of Solids. 1999; 60: 13–15

    1999

  36. [40]

    ZnS-based quantum dots as photocatalysts for water purification

    Sharma K, Raizada P, Hasija V, Singh P, Bajpai A, Nguyen V -H, et al. ZnS-based quantum dots as photocatalysts for water purification. Journal of Water Process Engineering. 2021; 43: 102217

    2021

  37. [41]

    Carbon quantum dots: A promising nanocarrier for bioimaging and drug delivery in cancer

    Jana P, Dev A. Carbon quantum dots: A promising nanocarrier for bioimaging and drug delivery in cancer . Materials Today Communications. 2022; 32: 104068

    2022

  38. [42]

    Carbon dots as nano -modules for energy conversion and storage

    Hasan AMM, Hasan Md A, Reza A, Islam Md M , Susan Md AB H. Carbon dots as nano -modules for energy conversion and storage. Materials Today Communications. 2021; 29: 102732

    2021

  39. [43]

    Graphene Quantum Dots

    Bacon M, Bradley SJ, Nann T. Graphene Quantum Dots. Particle & Particle Systems Characterization. 2014; 31: 415–428

    2014

  40. [44]

    Synthesis and characterization of graphene quantum dots

    Kundu S, Pillai VK. Synthesis and characterization of graphene quantum dots. Physical Sciences Reviews. 2019; 5

    2019

  41. [45]

    Increasing Cancer Therapy Efficiency through Targeting and Localized Light Activation

    Yang Y, Chen S, Liu L, Li S, Zeng Q, Zhao X, et al. Increasing Cancer Therapy Efficiency through Targeting and Localized Light Activation. ACS Applied Materials & Interfaces. 2017; 9: 23400–23408

    2017

  42. [46]

    Graphene quantum dots in biomedical applications: Recent advances and future challenges Frontiers in Laboratory Medicine

    Chen F, Gao W, Qiu X, Zhang H, Liu L, Liao P, et al. Graphene quantum dots in biomedical applications: Recent advances and future challenges Frontiers in Laboratory Medicine. 2017; 1: 192–199

    2017

  43. [47]

    Magnetically engineered Cd -free quantum dots as dual -modality probes for fluorescence/magnetic resonance imaging of tumors

    Ding K, Jing L, Liu C, Hou Y, Gao M. Magnetically engineered Cd -free quantum dots as dual -modality probes for fluorescence/magnetic resonance imaging of tumors. Biomaterials. 2014; 35: 1608–1617

    2014

  44. [48]

    Magnetically engineered semiconductor quantum dots as multimodal imaging probes

    Jing L, Ding K, Kershaw SV, Kempson IM, Rogach AL, Gao M. Magnetically engineered semiconductor quantum dots as multimodal imaging probes. Advanced Materials (Deerfield Beach, Fla.). 2014; 26: 6367–6386

    2014

  45. [49]

    Synthesis Mechanisms, Structural Models, and Photothermal Therapy Applications of Top-Down Carbon Dots from Carbon Powder, Graphite, Graphene, and Carbon Nanotubes

    Shi W, Han Q, Wu J, Ji C, Zhou Y, Li S, et al. Synthesis Mechanisms, Structural Models, and Photothermal Therapy Applications of Top-Down Carbon Dots from Carbon Powder, Graphite, Graphene, and Carbon Nanotubes. International Journal of Molecular Sciences. 2022; 23: 1456

    2022

  46. [50]

    Carbon Dots: Bottom -Up Syntheses, Properties, and Light -Harvesting Applications

    Choi Y, Choi Y, Kwon OH, Kim BS. Carbon Dots: Bottom -Up Syntheses, Properties, and Light -Harvesting Applications. Chemistry, an Asian Journal. 2018; 13: 586–598

    2018

  47. [51]

    Review article on Quantum Dots: Synthesis, Properties and Application

    Joglekar PV, Mandalkar DJ, Nikam MA, Pande N S, Dubal A. Review article on Quantum Dots: Synthesis, Properties and Application. International Journal of Research in Advent Technology. 2019; 7: 510–515

    2019

  48. [52]

    Quantum dots: synthesis, bioapplications, and toxicity

    Valizadeh A, Mikaeili H, Samiei M, Farkhani SM, Zarghami N, Kouhi M, et al. Quantum dots: synthesis, bioapplications, and toxicity. Nanoscale Research Letters. 2012; 7: 480

    2012

  49. [53]

    Quantum Dots: An Emerging Tool for Point-of-Care Testing

    Singh S, Dhawan A, Karhana S, Bhat M, Dinda AK. Quantum Dots: An Emerging Tool for Point-of-Care Testing. Micromachines. 2020; 11: 1058

    2020

  50. [54]

    Pillar-Little TJ, Wanninayake N, Nease L, Heidary DK, Glazer E C, Kim DY. Superior photodynamic effect of carbon quantum dots through both type I and type II pathways: Detailed comparison study of top -down-synthesized and bottom-up-synthesized carbon quantum dots. Carbon. 201...

    2018

  51. [55]

    Synthesis and characterization of aspartic acid -capped CdS/ZnS quantum dots in reverse micelles and its application to Hg(II) determination

    Hosseini MS, Kamali M. Synthesis and characterization of aspartic acid -capped CdS/ZnS quantum dots in reverse micelles and its application to Hg(II) determination. Journal of Luminescence. 2015; 167: 51–58

    2015

  52. [56]

    Local Formation of InAs Nanocrystals in Si by Masked Ion Implantation and Flash Lamp Annealing

    Rebohle L, Wutzler R, Prucnal S, Hübner R, Georgiev YM, Erbe A, et al. Local Formation of InAs Nanocrystals in Si by Masked Ion Implantation and Flash Lamp Annealing. Physica Status Solidi C. 2017; 14:

    2017

  53. [57]

    Directed Self-Assembly of Ge Quantum Dots Using Focused Si2+ Ion Beam Patterning

    Chee SW, Kammler M, Graham J, Gignac L, Reuter MC, Hull R, et al. Directed Self-Assembly of Ge Quantum Dots Using Focused Si2+ Ion Beam Patterning. Scientific Reports. 2018; 8: 9361

    2018

  54. [58]

    Recent Progress in Synaptic Devices Based on 2D Materials

    Sun L, Wang W,Yang H. Recent Progress in Synaptic Devices Based on 2D Materials. Advanced Intelligent Systems. 2020; 2

    2020

  55. [59]

    Designing silicon carbide heterostructures for quantum information science: challenges and opportunities

    Harmon KJ, Delegan N, Highland MJ, He H, Zapol P, Heremans FJ, et al. Designing silicon carbide heterostructures for quantum information science: challenges and opportunities. Materials for Quantum Technology. 2022; 2: 023001

    2022

  56. [60]

    Surface characterisation of PEO‐like microstructures by means of ToF‐SIMS, XPS and SPR

    Perez‐Roldan M, Colpo P, Gilliland D, Ceccone G , Rossi F. Surface characterisation of PEO‐like microstructures by means of ToF‐SIMS, XPS and SPR. Surface and Interface Analysis. 2013; 45: 240–243

    2013

  57. [61]

    Digital pattern generator: an electron-optical MEMS for massively parallel reflective electron beam lithography

    Grella L, Carroll A, Murray K, McCord M A, Tong WM, Brodie AD, et al. Digital pattern generator: an electron-optical MEMS for massively parallel reflective electron beam lithography . Journal of Micro/Nanolithography, MEMS, and MOEMS. 2013; 12: 031107

    2013

  58. [62]

    X-ray lithography

    Heuberger A. X-ray lithography. Microelectronic Engineering. 1986; 5: 3–38

    1986

  59. [63]

    Evolution in Lithography Techniques: Microlithography to Nanolithography

    Sharma E, Rathi R, Misharwal J, Sinhmar B, Kumari S, Dalal J, et al. Evolution in Lithography Techniques: Microlithography to Nanolithography. Nanomaterials (Basel, Switzerland). 2022; 12: 2754

    2022

  60. [64]

    Quantum Dots and Their Multimodal Applications: A Review

    Bera D, Qian L, Tseng T -K, Holloway P H. Quantum Dots and Their Multimodal Applications: A Review . Materials. 2010; 3: 2260–2345

    2010

  61. [65]

    Surface ligands in synthesis, modification, assembly and biomedical applications of nanoparticles Nano Today

    Ling D, Hackett MJ, Hyeon T. Surface ligands in synthesis, modification, assembly and biomedical applications of nanoparticles Nano Today. 2014; 9: 457–477

    2014

  62. [66]

    Surface-modified CdSe quantum dots for the sensitive and selective determination of Cu(II) in aqueous solutions by luminescent measurements

    Fernández-Argüelles MT, Jin WJ, Costa-Fernández JM, Pereiro R, Sanz-Medel A. Surface-modified CdSe quantum dots for the sensitive and selective determination of Cu(II) in aqueous solutions by luminescent measurements. Analytica Chimica Acta. 2005; 549: 20–25

    2005

  63. [67]

    Revisiting the principles of preparing aqueous quantum dots for biological applications: the effects of surface ligands on the physicochem ical properties of quantum dots

    Zhang B, Hu R, Wang Y, Yang C, Liu X, Yong K-T. Revisiting the principles of preparing aqueous quantum dots for biological applications: the effects of surface ligands on the physicochem ical properties of quantum dots. RSC Advances. 2014; 4: 13805– 13816

    2014

  64. [68]

    Effect of surface ligands on the optical properties of aqueous soluble CdTe quantum dots

    Silva FO, Carvalho MS, Mendonça R, Macedo WA, Balzuweit K, Reiss P, et al. Effect of surface ligands on the optical properties of aqueous soluble CdTe quantum dots. Nanoscale Research Letters. 2012; 7: 536

    2012

  65. [69]

    Silanization of quantum dots: Challenges and perspectives

    Drozd D, Zhang H, Goryacheva I, De Saeger S, Beloglazova NV. Silanization of quantum dots: Challenges and perspectives. Talanta. 2019; 205: 120164

    2019

  66. [70]

    Facile synthesis, silanization, and biodistribution of biocompatible quantum dots

    Ma N, Marshall AF, Gambhir SS, Rao J. Facile synthesis, silanization, and biodistribution of biocompatible quantum dots. Small (Weinheim an Der Bergstrasse, Germany). 2010; 6: 1520–1528

    2010

  67. [71]

    Surface Modifications Technology of Quantum Dots Based Biosensors and Their Medical Applications Chinese Journal of Analytical Chemistry

    Liu X, Luo Y. Surface Modifications Technology of Quantum Dots Based Biosensors and Their Medical Applications Chinese Journal of Analytical Chemistry. 2014; 42: 1061–1069

    2014

  68. [72]

    Adsorption of quantum dots onto polymer and Gemini surfactant films: a quartz crystal microbalance study

    Alejo T, Merchán MD, Velázquez MM. Adsorption of quantum dots onto polymer and Gemini surfactant films: a quartz crystal microbalance study. Langmuir: the ACS Journal of Surfaces and Colloids. 2014; 30: 9977–9984

    2014

  69. [73]

    Quantum Dots in an Amphiphilic Polyethyleneimine Derivative Platform for Cellular Labeling, Targeting, Gene Delivery, and Ratiometric Oxygen Sensing

    Park J, Lee J, Kwag J, Baek Y, Kim B, Yoon CJ, et al. Quantum Dots in an Amphiphilic Polyethyleneimine Derivative Platform for Cellular Labeling, Targeting, Gene Delivery, and Ratiometric Oxygen Sensing. ACS Nano. 2015; 9: 6511–6521

    2015

  70. [74]

    Direct Visualization of Ligands Exchange on the Surfaces of Quantum Dots by a Two-Phase Approach

    Nie X, Zhang Y, Wang X, Ren C, Gao S -Q, Lin Y-W. Direct Visualization of Ligands Exchange on the Surfaces of Quantum Dots by a Two-Phase Approach. ChemistrySelect. 2018; 3: 2267–2271

    2018

  71. [75]

    Highly bright water-soluble silica coated quantum dots with excellent stability

    Ma Y, Li Y, Ma S, Zhong X. Highly bright water-soluble silica coated quantum dots with excellent stability. Journal of Materials Chemistry. B. 2014; 2: 5043–5051

    2014

  72. [76]

    Preparation and characterization of CdSe/ZnS quantum dots encapsulated in poly(ethylene glycol)-b-poly(D,L-lactide) micelle nanoparticles

    Lee J, Im JH, Huh KM, Lee YK, Shin H. Preparation and characterization of CdSe/ZnS quantum dots encapsulated in poly(ethylene glycol)-b-poly(D,L-lactide) micelle nanoparticles. Journal of Nanoscience and Nanotechnology. 2010; 10: 487 – 496

    2010

  73. [77]

    A Review on Characterization Techniques for Carbon Quantum Dots and Their Applications in Agrochemical Residue Detection

    John BK, Abraham T, Mathew B. A Review on Characterization Techniques for Carbon Quantum Dots and Their Applications in Agrochemical Residue Detection. Journal of Fluorescence. 2022; 32: 449–471

    2022

  74. [78]

    Excited states of individual quantum dots studied by photoluminescence spectroscopy

    H essman D, Castrillo P, Pistol M‐E , Pryor C , Samuelson L . Excited states of individual quantum dots studied by photoluminescence spectroscopy. Applied Physics Letters. 1996; 69: 749–751

    1996

  75. [79]

    Investigating the bioavailability of graphene quantum dots in lung tissues via Fourier transform infrared spectroscopy

    Tabish TA, Lin L, Ali M, Jabeen F, Ali M, Iqbal R, et al. Investigating the bioavailability of graphene quantum dots in lung tissues via Fourier transform infrared spectroscopy. Interface Focus. 2018; 8: 20170054

    2018

  76. [80]

    Optical characterisation of MOVPE grown vertically correlated InAs/GaAs quantum dots

    Hazdra P, Voves J, Oswald J, Kuldová K, Hospodková A, Hulicius E, et al. Optical characterisation of MOVPE grown vertically correlated InAs/GaAs quantum dots. Microelectronics Journal. 2008; 39: 1070–1074

    2008

  77. [81]

    Determination of size and composition of optically active CdZnSe/ZnBeSe quantum dots

    Gu Y, Kuskovsky IL, Fung J, Robinson R, Herman IP, Neumark G F, et al. Determination of size and composition of optically active CdZnSe/ZnBeSe quantum dots. Applied Physics Letters. 2003; 83; 3779–3781

    2003

  78. [82]

    Antibonding ground states in InAs quantum- dot molecules

    Doty MF, Climente JI, Korkusinski M, Scheibner M, Bracker AS, Hawrylak P, et al. Antibonding ground states in InAs quantum- dot molecules. Physical Review Letters. 2009; 102: 047401

    2009

  79. [83]

    Experimental determination of quantum dot size distributions, ligand packing densities, and bioconjugation using analytical ultracentrifugation

    Lees EE, Gunzburg MJ, Nguyen TL, Howlett GJ, Rothacker J, Nice EC, et al. Experimental determination of quantum dot size distributions, ligand packing densities, and bioconjugation using analytical ultracentrifugation. Nano Letters. 2008; 8: 2883–2890

    2008

  80. [84]

    Quantum dots - characterization, preparation and usage in biological systems

    Drbohlavova J, Adam V, Kizek R, Hubalek J. Quantum dots - characterization, preparation and usage in biological systems. International Journal of Molecular Sciences. 2009; 10: 656–673

    2009

  81. [85]

    In vivo molecular and cellular imaging with quantum dots

    Gao X, Yang L, Petros JA, Marshall FF, Simons JW, Nie S. In vivo molecular and cellular imaging with quantum dots. Curre nt Opinion in Biotechnology. 2005; 16: 63–72

    2005

  82. [86]

    Quantum dots for fluorescent biosensing and bio-imaging applications

    Li J, Zhu JJ. Quantum dots for fluorescent biosensing and bio-imaging applications. The Analyst. 2013; 138: 2506–2515

    2013

  83. [87]

    Fluorescent quantum dots: synthesis, biomedical optical imaging, and biosafety assess ment

    Ji X, Peng F, Zhong Y, Su Y, He Y. Fluorescent quantum dots: synthesis, biomedical optical imaging, and biosafety assess ment. Colloids and Surfaces. B, Biointerfaces. 2014; 124: 132–139

    2014

  84. [88]

    Observing photophysical properties of quantum dots in air at the single molecule level: advantages in microarray applications

    Shi X, Meng X, Sun L, Liu J, Zheng J, Gai H, et al. Observing photophysical properties of quantum dots in air at the single molecule level: advantages in microarray applications. Lab on a Chip. 2010; 10: 2844–2847

    2010

  85. [89]

    Biocompatible carbon dots with low -saturation-intensity and high - photobleaching-resistance for STED nanoscopy imaging of the nucleolus and tunneling nanotubes in living cells

    Li H, Ye S, Guo J, Wang H, Yan W, Song J , et al. Biocompatible carbon dots with low -saturation-intensity and high - photobleaching-resistance for STED nanoscopy imaging of the nucleolus and tunneling nanotubes in living cells. Nano Research. 2019; 12: 3075–3084

    2019

  86. [90]

    Bio-Conjugated Quantum Dots for Cancer Research: Detection and Imaging

    Liang Z, Khawar MB, Liang J, Sun H. Bio-Conjugated Quantum Dots for Cancer Research: Detection and Imaging. Frontiers in Oncology. 2021; 11: 749970

    2021

  87. [91]

    Quantum -dot-labeled DNA probes for fluorescence in situ hybridization (FISH) in the microorganism Escherichia coli

    Wu SM, Zhao X, Zhang ZL, Xie HY, Tian ZQ, Peng J, et al . Quantum -dot-labeled DNA probes for fluorescence in situ hybridization (FISH) in the microorganism Escherichia coli. Chemphyschem: a European Journal of Chemical Physics and Physical Chemistry. 2006; 7: 1062–1067

    2006

  88. [92]

    Quantum dots for live cell and in vivo imaging

    Walling MA, Novak JA, Shepard JRE. Quantum dots for live cell and in vivo imaging. International Journal of Molecular Sciences. 2009; 10: 441–491

    2009

  89. [93]

    Quantum Dots for In Vivo Molecular and Cellular Imaging

    Gao X, Chung LWK, Nie S. Quantum Dots for In Vivo Molecular and Cellular Imaging. In Bruchez MP, Hotz CZ (eds.) Quantum Dots (pp 135–146). Humana Press: New Jersey. 2007

    2007

  90. [94]

    In vivo NIR fluorescence imaging, biodistribution, and toxicology of photoluminescent carbon dots produced from carbon nanotubes and graphite

    Tao H, Yang K, Ma Z, Wan J, Zhang Y, Kang Z, et al. In vivo NIR fluorescence imaging, biodistribution, and toxicology of photoluminescent carbon dots produced from carbon nanotubes and graphite. Small (Weinheim an Der Bergstrasse, Germany). 2012; 8: 281–290

    2012

  91. [95]

    Facile Synthesis of Gd -Cu-In-S/ZnS Bimodal Quantum Dots with Optimized Properties for Tumor Targeted Fluorescence/MR In Vivo Imaging

    Yang W, Guo W, Gong X, Zhang B, Wang S, Chen N, et al. Facile Synthesis of Gd -Cu-In-S/ZnS Bimodal Quantum Dots with Optimized Properties for Tumor Targeted Fluorescence/MR In Vivo Imaging. ACS Applied Materials & Interfaces. 2015; 7: 18759–18768

    2015

  92. [96]

    Magnetic quantum dots for multimodal imaging

    Koole R, Mulder WJM, van Schooneveld MM, Strijkers GJ, Meijerink A, Nicolay K. Magnetic quantum dots for multimodal imaging. Wiley Interdisciplinary Reviews. Nanomedicine and Nanobiotechnology. 2009; 1: 475–491

    2009

  93. [97]

    Quantum dots for multimodal molecular imaging of angiogenesis

    Mulder WJM, Strijkers GJ, Nicolay K, Griffioen AW. Quantum dots for multimodal molecular imaging of angiogenesis. Angiogenesis. 2010; 13: 131–134

    2010

  94. [98]

    Carbon Quantum Dots Codoped with Nitrogen and Lanthanides for Multimodal Imaging

    Bouzas‐Ramos D, Cigales Canga J, Mayo JC, Sainz R M, Ruiz Encinar J, Costa‐Fernandez JM. Carbon Quantum Dots Codoped with Nitrogen and Lanthanides for Multimodal Imaging. Advanced Functional Materials. 2019; 29: 1903884

    2019

  95. [99]

    Facile Preparation of Double Rare Earth -Doped Carbon Dots for MRI/CT/FI Multimodal Imaging

    Zhao Y, Hao X, Lu W, Wang R, Shan X, Chen Q, et al. Facile Preparation of Double Rare Earth -Doped Carbon Dots for MRI/CT/FI Multimodal Imaging. ACS Applied Nano Materials - ACS Publications. 2018; 1; 2544–2551

    2018

  96. [100]

    Core/shell quantum dots with high relaxivity and photoluminescence for multimodality imaging

    Wang S, Jarrett BR, Kauzlarich SM, Louie AY. Core/shell quantum dots with high relaxivity and photoluminescence for multimodality imaging. Journal of the American Chemical Society. 2007; 129: 3848–3856

    2007

  97. [101]

    Ultrasmall Magnetically Engineered Ag2Se Quantum Dots for Instant Efficient Labeling and Whole-Body High-Resolution Multimodal Real-Time Tracking of Cell-Derived Microvesicles

    Zhao JY, Chen G, Gu YP, Cui R, Zhang ZL, Yu ZL, et al. Ultrasmall Magnetically Engineered Ag2Se Quantum Dots for Instant Efficient Labeling and Whole-Body High-Resolution Multimodal Real-Time Tracking of Cell-Derived Microvesicles. Journal of the American Chemical Society. 201...

    2016

  98. [102]

    Synthesis and Characterization of Mn:ZnSe/ZnS/ZnMnS Sandwiched QDs for Multimodal Imaging and Theranostic Applications

    Wang Y, Wu B, Yang C, Liu M, Sum TC, Yong KT. Synthesis and Characterization of Mn:ZnSe/ZnS/ZnMnS Sandwiched QDs for Multimodal Imaging and Theranostic Applications. Small (Weinheim an Der Bergstrasse, Germany). 2016; 12: 534–546

    2016

  99. [103]

    Quantum dots as a platform for nanoparticle drug delivery vehicle design

    Probst CE, Zrazhevskiy P, Bagalkot V, Gao X. Quantum dots as a platform for nanoparticle drug delivery vehicle design. Advanced Drug Delivery Reviews. 2013; 65: 703–718

    2013

  100. [104]

    Emerging application of quantum dots for drug delivery and therapy

    Qi L, Gao X. Emerging application of quantum dots for drug delivery and therapy. Expert Opinion on Drug Delivery. 2008; 5: 263–267

    2008

  101. [105]

    Quantum dots for live cells, in vivo imaging, and diagnostics

    Michalet X, Pinaud FF, Bentolila LA, Tsay JM, Doose S, Li JJ, et al . Quantum dots for live cells, in vivo imaging, and diagnostics. Science (New York, N.Y.). 2005; 307: 538–544

    2005

  102. [106]

    Oligonucleotide -based theranostic nanoparticles in cancer therapy

    Shahbazi R, Ozpolat B, Ulubayram K. Oligonucleotide -based theranostic nanoparticles in cancer therapy. Nanomedicine (London, England). 2016; 11: 1287–1308

    2016

  103. [107]

    Quantum dot-based theranostics

    Ho YP, Leong KW. Quantum dot-based theranostics. Nanoscale. 2010; 2: 60–68

    2010

  104. [110]

    Lactoferrin-tagged quantum dots-based theranostic nanocapsules for combined COX -2 inhibitor/herbal therapy of breast cancer

    AbdElhamid AS, Zayed DG, Helmy MW, Ebrahim SM, Bahey-El-Din M, Zein-El-Dein EA, et al. Lactoferrin-tagged quantum dots-based theranostic nanocapsules for combined COX -2 inhibitor/herbal therapy of breast cancer. Nanomedicine (London, England). 2018; 13: 2637–2656

    2018

  105. [111]

    Insight into the cellular internalization and cytotoxicity of graphene qua ntum dots

    Wu C, Wang C, Han T, Zhou X, Guo S, Zhang J. Insight into the cellular internalization and cytotoxicity of graphene qua ntum dots. Advanced Healthcare Materials. 2013; 2: 1613–1619

    2013

  106. [112]

    Synthesis of graphene quantum dots and their applications in drug delivery

    Zhao C, Song X, Liu Y, Fu Y, Ye L, Wang N, et al. Synthesis of graphene quantum dots and their applications in drug delivery. Journal of Nanobiotechnology. 2020; 18: 142

    2020

  107. [113]

    Graphene quantum dots for cancer targeted drug delivery

    Iannazzo D, Pistone A, Salamò M, Galvagno S, Romeo R, Giofré SV, et al. Graphene quantum dots for cancer targeted drug delivery. International Journal of Pharmaceutics. 2017; 518: 185–192

    2017

  108. [114]

    Natural carbon-based quantum dots and their applications in drug delivery: A review

    Nair A, Haponiuk JT, Thomas S, Gopi S. Natural carbon-based quantum dots and their applications in drug delivery: A review. Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie. 2020; 132: 110834

    2020

  109. [115]

    Carbon Dots with Intrinsic Theranostic Properties for Bioimaging, Red-Light- Triggered Photodynamic/Photothermal Simultaneous Therapy In Vitro and In Vivo

    Ge J, Jia Q, Liu W, Lan M, Zhou B, Guo L, et al. Carbon Dots with Intrinsic Theranostic Properties for Bioimaging, Red-Light- Triggered Photodynamic/Photothermal Simultaneous Therapy In Vitro and In Vivo. Advanced Healthcare Materials. 2016; 5: 665–675

    2016

  110. [116]

    Paclitaxel -liposome-microbubble complexes as ultrasound -triggered therapeutic drug delivery carriers

    Yan F, Li L, Deng Z, Jin Q, Chen J, Yang W, et al . Paclitaxel -liposome-microbubble complexes as ultrasound -triggered therapeutic drug delivery carriers. Journal of Controlled Release: Official Journal of the Controlled Release Society. 2013; 166: 246–255

    2013

  111. [117]

    Enabling anticancer therapeutics by nanoparticle carriers: the delivery of Paclitaxel

    Liu Y, Zhang B, Yan B. Enabling anticancer therapeutics by nanoparticle carriers: the delivery of Paclitaxel. International Journal of Molecular Sciences. 2011; 12: 4395–4413

    2011

  112. [118]

    Synthesis of multimodal polymersomes for targeted drug delivery and MR/fluorescence imaging in metastatic breast cancer model

    Zavvar T, Babaei M, Abnous K, Taghdisi SM, Nekooei S, Ramezani M, et al. Synthesis of multimodal polymersomes for targeted drug delivery and MR/fluorescence imaging in metastatic breast cancer model. International Journal of Pharmaceutics. 2020; 578: 119091

    2020

  113. [120]

    pH-Sensitive ZnO Quantum Dots-Doxorubicin Nanoparticles for Lung Cancer Targeted Drug Delivery

    Cai X, Luo Y, Zhang W, Du D, Lin Y. pH-Sensitive ZnO Quantum Dots-Doxorubicin Nanoparticles for Lung Cancer Targeted Drug Delivery. ACS Applied Materials & Interfaces. 2016; 8: 22442–22450

    2016

  114. [121]

    Gold -doxorubicin nanoconjugates for overcoming multidrug resistance

    Gu YJ, Cheng J, Man CWY, Wong WT, Cheng SH. Gold -doxorubicin nanoconjugates for overcoming multidrug resistance. Nanomedicine: Nanotechnology, Biology, and Medicine. 2012; 8: 204–211

    2012

  115. [122]

    Quantum dots as targeted doxorubicin drug delivery nanosystems in human lung cancer cells

    Ruzycka -Ayoush M, Kowalik P, Kowalczyk A, Bujak P, Nowicka A M, Wojewodzka M, et al. Quantum dots as targeted doxorubicin drug delivery nanosystems in human lung cancer cells. Cancer Nanotechnology. 2021; 12: 8

    2021

  116. [123]

    A tumoral acidic pH -responsive drug delivery system based on a novel photosensitizer (fullerene) for in vitro and in vivo chemo-photodynamic therapy

    Shi J, Liu Y, Wang L, Gao J, Zhang J, Yu X, et al. A tumoral acidic pH -responsive drug delivery system based on a novel photosensitizer (fullerene) for in vitro and in vivo chemo-photodynamic therapy. Acta Biomaterialia. 2014; 10: 1280–1291

    2014

  117. [125]

    Renal clearance of quantum dots

    Choi HS, Liu W, Misra P, Tanaka E, Zimmer JP, Itty Ipe B, et al. Renal clearance of quantum dots. Nature Biotechnology. 2007; 25: 1165–1170

    2007

  118. [126]

    What do we (need to) know about the kinetic properties of nanoparticles in the body? Regulatory Toxicology and Pharmacology: RTP

    Hagens WI, Oomen AG, de Jong WH, Cassee FR, Sips AJAM. What do we (need to) know about the kinetic properties of nanoparticles in the body? Regulatory Toxicology and Pharmacology: RTP. 2007; 49: 217–229

    2007

  119. [127]

    Extrapulmonary translocation of ultrafine carbon particles following whole-body inhalation exposure of rats

    Oberdörster G, Sharp Z, Atudorei V, Elder A, Gelein R, Lunts A, et al. Extrapulmonary translocation of ultrafine carbon particles following whole-body inhalation exposure of rats. Journal of Toxicology and Environmental Health. Part a. 2002; 65: 1531–1543

    2002

  120. [128]

    A toxicologic review of quantum dots: toxicity depends on physicochemical and environmental factors

    Hardman R. A toxicologic review of quantum dots: toxicity depends on physicochemical and environmental factors. Environmental Health Perspectives. 2006; 114: 165–172

    2006

  121. [129]

    Noninvasive imaging of quantum dots in mice

    Ballou B, Lagerholm BC, Ernst LA, Bruchez MP, Waggoner AS. Noninvasive imaging of quantum dots in mice. Bioconjugate Chemistry. 2004; 15: 79–86

    2004

  122. [130]

    Functionalized quantum dots for biosensing and bioimaging and concerns on toxicity

    Wang Y, Hu R, Lin G, Roy I, Yong KT. Functionalized quantum dots for biosensing and bioimaging and concerns on toxicity . ACS Applied Materials & Interfaces. 2013; 5: 2786–2799

    2013

  123. [131]

    Graphene quantum dots: Synthesis, optical properties and navigational applications against cancer

    Kansara V, Shukla R, Flora SJ S, Bahadur P, Tiwari S. Graphene quantum dots: Synthesis, optical properties and navigational applications against cancer. Materials Today Communications. 2022; 31; 103359

    2022

  124. [132]

    Tuning the optical properties of graphene quantum dots for biosensing and bioimaging

    Hai X, Feng J, Chen X, Wang J. Tuning the optical properties of graphene quantum dots for biosensing and bioimaging. Journal of Materials Chemistry. B. 2018; 6: 3219–3234

    2018

  125. [133]

    Properties and application of carbon quantum dots (CQDs) in biosensors for disease detection: A comprehensive review

    Pourmadadi M, Rahmani E, Rajabzadeh-Khosroshahi M, Samadi A, Behzadmehr R, Rahdar A, et al. Properties and application of carbon quantum dots (CQDs) in biosensors for disease detection: A comprehensive review . Journal of Drug Delivery Science and Technology. 2023; 80: 104156

    2023

  126. [134]

    Immunochromatographic assay for quantitative and sensitive detection of hepatitis B virus surface antigen using highly luminescent quantum dot-beads

    Shen J, Zhou Y, Fu F, Xu H, Lv J, Xiong Y, et al. Immunochromatographic assay for quantitative and sensitive detection of hepatitis B virus surface antigen using highly luminescent quantum dot-beads. Talanta. 2015; 142: 145–149

    2015

  127. [135]

    Carbon dots: Current advances in pathogenic bacteria monitoring and prospect applications

    Cui F, Ye Y, Ping J, Sun X. Carbon dots: Current advances in pathogenic bacteria monitoring and prospect applications. Biosensors & Bioelectronics. 2020; 156: 112085

    2020

  128. [136]

    Membrane-Penetrating Carbon Quantum Dots for Imaging Nucleic Acid Structures in Live Organisms

    Han G, Zhao J, Zhang R, Tian X, Liu Z, Wang A, et al. Membrane-Penetrating Carbon Quantum Dots for Imaging Nucleic Acid Structures in Live Organisms. Angewandte Chemie (International Ed. in English). 2019; 58: 7087–7091

    2019

  129. [137]

    Quantum Dots Applied to Methodology on Detection of Pesticide and Veterinary Drug Residues

    Zhou JW, Zou XM, Song SH, Chen GH. Quantum Dots Applied to Methodology on Detection of Pesticide and Veterinary Drug Residues. Journal of Agricultural and Food Chemistry. 2018; 66: 1307–1319

    2018

  130. [138]

    Quantum dots for Förster Resonance Energy Transfer (FRET) TrAC

    Cardoso Dos Santos M, Algar WR, Medintz I L, Hildebrandt N. Quantum dots for Förster Resonance Energy Transfer (FRET) TrAC. Trends in Analytical Chemistry. 2020; 125: 115819

    2020

  131. [139]

    Förster resonance energy transfer in finite length systems and porous media

    León-Simón G, Lazcano Z, Pérez E , Meza O. Förster resonance energy transfer in finite length systems and porous media . Materials Today Communications. 2022; 30: 102961

    2022

  132. [140]

    Recent advances on fluorescent biomarkers of near -infrared quantum dots for in vitro and in vivo imaging

    Chinnathambi S, Shirahata N. Recent advances on fluorescent biomarkers of near -infrared quantum dots for in vitro and in vivo imaging. Science and Technology of Advanced Materials. 2019; 20: 337–355

    2019

  133. [141]

    Fluorescent graphene quantum dots for biosensing and bioimaging

    Fan Z, Li S, Yuan F, Fan L. Fluorescent graphene quantum dots for biosensing and bioimaging. RSC Advances. 2015; 5: 19773– 19789

    2015

  134. [142]

    Graphene Quantum Dots for Optical Bioimaging

    Lu H, Li W, Dong H, Wei M. Graphene Quantum Dots for Optical Bioimaging. Small (Weinheim an Der Bergstrasse, Germany). 2019; 15: e1902136

    2019

  135. [143]

    In Vivo Imaging of Single Tumor Cells in Fast -Flowing Bloodstream Using Near-Infrared Quantum Dots and Time-Gated Imaging

    Pons T, Bouccara S, Loriette V, Lequeux N, Pezet S, Fragola A. In Vivo Imaging of Single Tumor Cells in Fast -Flowing Bloodstream Using Near-Infrared Quantum Dots and Time-Gated Imaging. ACS Nano. 2019; 13: 3125–3131

    2019

  136. [144]

    Antibody-free detection of infectious bacteria using quantum dots-based barcode assay

    Cihalova K, Hegerova D, Jimenez AM, Milosavljevic V, Kudr J, Skalickova S, et al. Antibody-free detection of infectious bacteria using quantum dots-based barcode assay. Journal of Pharmaceutical and Biomedical Analysis. 2017; 134: 325–332

    2017

  137. [145]

    Multienzyme detection and in-situ monitoring of enzyme activity by bending CE using quantum dots-based polypeptide substrate

    Qiu L, Cui P, Zhu Z, Xu M, Jia W, Sheng J, et al. Multienzyme detection and in-situ monitoring of enzyme activity by bending CE using quantum dots-based polypeptide substrate. Electrophoresis. 2020; 41: 1103–1108

    2020

  138. [146]

    Multifunctional Single-Layered Graphene Quantum Dots Used for Diagnosis of Mitochondrial Malfunction-Related Diseases

    Jiang XL, Liu JH, Que YT, Que YM, Hu PP, Huang CZ, et al. Multifunctional Single-Layered Graphene Quantum Dots Used for Diagnosis of Mitochondrial Malfunction-Related Diseases. ACS Biomaterials Science & Engineering. 2020; 6: 1727–1734

    2020

  139. [147]

    Toxicity of quantum dots on target organs and immune system

    Liang Y, Zhang T, Tang M. Toxicity of quantum dots on target organs and immune system. Journal of Applied Toxicology: JAT. 2022; 42: 17–40

    2022

  140. [148]

    Quantum dots: Applications and safety consequences

    Reshma VG, Mohanan PV. Quantum dots: Applications and safety consequences . Journal of Luminescence. 2019; 205: 287– 298

    2019

  141. [149]

    Nanomedicines for hepatocellular carcinoma therapy: Challenges and clinical applications

    Sedighi M, Mahmou di Z, Abbaszadeh S, Eskandari M R, Saeinasab M , Sefat F. Nanomedicines for hepatocellular carcinoma therapy: Challenges and clinical applications. Materials Today Communications. 2023; 34: 105242

    2023

  142. [150]

    Review of toxicological effect of quantum dots on the liver

    Lu J, Tang M, Zhang T. Review of toxicological effect of quantum dots on the liver. Journal of Applied Toxicology: JAT. 2019; 39: 72–86

    2019

  143. [151]

    Mitochondrial dynamics and mitophagy involved in MPA -capped CdTe quantum dots - induced toxicity in the human liver carcinoma (HepG2) cell line

    Wu D, Lu J, Ma Y, Cao Y, Zhang T. Mitochondrial dynamics and mitophagy involved in MPA -capped CdTe quantum dots - induced toxicity in the human liver carcinoma (HepG2) cell line. Environmental Pollution (Barking, Essex: 1987). 2021; 274: 115681

    1987

  144. [152]

    Toxicity of quantum dots on respiratory system

    Wu T, Tang M. Toxicity of quantum dots on respiratory system. Inhalation Toxicology. 2014; 26: 128–139

    2014

  145. [153]

    Quantum dots cause acute systemic toxicity in lactating rats and growth restriction of offspring

    Yang L, Kuang H, Zhang W, Wei H, Xu H. Quantum dots cause acute systemic toxicity in lactating rats and growth restriction of offspring. Nanoscale. 2018; 10: 11564–11577

    2018

  146. [154]

    Stern ST, Zolnik BS, McLeland CB, Clogston J, Zheng J, McNeil SE. Induction of autophagy in porcine kidney cells by quantum dots: a common cellular response to nanomaterials? Toxicological Sciences: an Official Journal of the Society of Toxicology. 2008; 106: 140–152

    2008

  147. [155]

    Quantum Dot Cellular Uptake and Toxicity in the Developing Brain: Implications for Use as Imaging Probes

    Zhang M, Bishop BP, Thompson NL, Hildahl K, Dang B, Mironchuk O, et al. Quantum Dot Cellular Uptake and Toxicity in the Developing Brain: Implications for Use as Imaging Probes. Nanoscale Advances. 2019; 1: 3424–3442

    2019

  148. [156]

    Quantum dot therapeutics: a new class of radical therapies

    Levy M, Chowdhury PP, Nagpal P. Quantum dot therapeutics: a new class of radical therapies. Journal of Biological Engineering. 2019; 13: 48

    2019

  149. [157]

    Immunotoxicity assessment of CdSe/ZnS quantum dots in macrophages, lymphocytes and BALB/c mice

    Wang X, Tian J, Yong KT, Zhu X, Lin MCM, Jiang W, et al . Immunotoxicity assessment of CdSe/ZnS quantum dots in macrophages, lymphocytes and BALB/c mice. Journal of Nanobiotechnology. 2016; 14: 10

    2016

  150. [158]

    Toxicity of Graphene Quantum Dots in Zebrafish Embryo

    Wang ZG, Zhou R, Jiang D, Song JE, Xu Q, Si J, et al. Toxicity of Graphene Quantum Dots in Zebrafish Embryo. Biomedical and Environmental Sciences: BES. 2015; 28: 341–351

    2015

  151. [159]

    Comparison of Toxicity of CdSe: ZnS Quantum Dots on Male Reproductive System in Different Stages of Development in Mice

    Amiri G, Valipoor A, Parivar K, Modaresi M, Noori A, Gharamaleki H, et al. Comparison of Toxicity of CdSe: ZnS Quantum Dots on Male Reproductive System in Different Stages of Development in Mice. International Journal of Fertility & Sterility. 2016; 9: 512–520

    2016

  152. [160]

    The Reproductive Toxicity of CdSe/ZnS Quantum Dots on the in vivo Ovarian Function and in vitro Fertilization

    Xu G, Lin G, Lin S, Wu N, Deng Y, Feng G, et al. The Reproductive Toxicity of CdSe/ZnS Quantum Dots on the in vivo Ovarian Function and in vitro Fertilization. Scientific Reports. 2016; 6: 37677

    2016

  153. [161]

    Carbon Quantum Dots for Zebrafish Fluorescence Imaging

    Kang YF, Li YH, Fang YW, Xu Y, Wei XM, Yin XB. Carbon Quantum Dots for Zebrafish Fluorescence Imaging. Scientific Reports. 2015; 5: 11835

    2015

  154. [162]

    Quantum dot weathering results in microbial toxicity

    Mahendra S, Zhu H, Colvin VL, Alvarez PJ. Quantum dot weathering results in microbial toxicity. Environmental Science & Technology. 2008; 42: 9424–9430

    2008

  155. [163]

    Mitigating the toxic effects of CdSe quantum dots towards freshwater alga Scenedesmus obliquus: Role of eco-corona

    Chakraborty D, Ethiraj KR, Chandrasekaran N, Mukherjee A. Mitigating the toxic effects of CdSe quantum dots towards freshwater alga Scenedesmus obliquus: Role of eco-corona. Environmental Pollution (Barking, Essex: 1987). 2021; 270: 116049

    1987

  156. [164]

    Mitigating the Cytotoxicity of Graphene Quantum Dots and Enhancing Their Applications in Bioimaging and Drug Delivery

    Chandra A, Deshpande S, Shinde DB, Pillai VK, Singh N. Mitigating the Cytotoxicity of Graphene Quantum Dots and Enhancing Their Applications in Bioimaging and Drug Delivery. ACS Macro Letters. 2014; 3: 1064–1068

    2014

  157. [165]

    Mitigation of quantum dot cytotoxicity by microencapsulation

    Romoser A, Ritter D, Majitha R, Meissner KE, McShane M, Sayes CM. Mitigation of quantum dot cytotoxicity by microencapsulation. PloS One. 2011; 6: e22079

    2011

  158. [166]

    A titanium dioxide/nitrogen-doped graphene quantum dot nanocomposite to mitigate cytotoxicity: synthesis, characterisation, and cell viability evaluation

    Ramachandran P, Lee CY, Doong RA, Oon CE, Kim Thanh NT, Lee HL. A titanium dioxide/nitrogen-doped graphene quantum dot nanocomposite to mitigate cytotoxicity: synthesis, characterisation, and cell viability evaluation. RSC Advances. 2020; 1 0: 21795–21805

    2020

  159. [167]

    Understanding the theranostic potential of quantum dots in cancer management

    Khan MS, Sheikh A, Abourehab MA S, Gupta N , Kesharwani P . Understanding the theranostic potential of quantum dots in cancer management. Materials Today Communications. 2023; 36: 106424

    2023

  160. [168]

    Applications of T -lymphoma labeled with fluorescent quantum dots to cell tracing markers in mouse body

    Hoshino A, Hanaki KI, Suzuki K, Yamamoto K. Applications of T -lymphoma labeled with fluorescent quantum dots to cell tracing markers in mouse body. Biochemical and Biophysical Research Communications. 2004; 314: 46–53

    2004

  161. [169]

    The role of surface chemistry in determining in vivo biodistribution and toxicity of CdSe/ZnS core-shell quantum dots

    Tang Y, Han S, Liu H, Chen X, Huang L, Li X, et al. The role of surface chemistry in determining in vivo biodistribution and toxicity of CdSe/ZnS core-shell quantum dots. Biomaterials. 2013; 34: 8741–8755

    2013

  162. [170]

    Differences in subcellular distribution and toxicity of green and red emitting CdTe quantum dots

    Lovrić J, Bazzi HS, Cuie Y, Fortin GRA, Winnik FM, Maysinger D. Differences in subcellular distribution and toxicity of green and red emitting CdTe quantum dots. Journal of Molecular Medicine (Berlin, Germany). 2005; 83: 377–385

    2005

  163. [171]

    Quantum dots in biomedical applications

    Wagner AM, Knipe JM, Orive G, Peppas NA. Quantum dots in biomedical applications. Acta Biomaterialia. 2019; 94: 44–63

    2019

  164. [172]

    Quantum dots in biomedical applications: advances and challenges

    Cinteza LO. Quantum dots in biomedical applications: advances and challenges. J Nanophotonics. 2010; 4: 042503

    2010

  165. [173]

    Current Status and Future Prospects of Semiconductor Quantum Dots in Botany

    Pang C, Gong Y. Current Status and Future Prospects of Semiconductor Quantum Dots in Botany. Journal of Agricultural an d Food Chemistry. 2019; 67: 7561–7568

    2019

  166. [174]

    Carbon-based designer and programmable fluorescent quantum dots for targeted biological and biomedical applications

    Barve K, Singh U, Yadav P, Bhatia D. Carbon-based designer and programmable fluorescent quantum dots for targeted biological and biomedical applications. Materials Chemistry Frontiers. 2023; 7: 1781–802

    2023

  167. [175]

    Graphene quantum dots redefine nanobiomedicine

    Henna TK, Pramod K. Graphene quantum dots redefine nanobiomedicine. Materials Science & Engineering. C, Materials for Biological Applications. 2020; 110: 110651

    2020

  168. [176]

    Recent advances in the biomedical applications of black phosphorus quantum dots

    Miao Y, Wang X, Sun J, Yan Z. Recent advances in the biomedical applications of black phosphorus quantum dots. Nanoscale Advances. 2021; 3: 1532–1550

    2021

Pith tools

Reviewed August 7, 2026 · model on record in the stance chip above.